[1]
AlShoaibi, I., Abdo, B., Abdullah, M., Alzanen, K., Alhakamy, M., Al-Namer, M., Al-Hagri, A., Salah, M., Salem, A., Almogahed, M., Alnadhari, I. and Ahmed, F. 2024. Effect of DOPA decarboxylase inhibitor supplements on the incidence of urinary tract infections in Parkinson’s disease patients: A systematic review and meta-analysis of randomized controlled trials. Archivio Italiano di Urologia e Andrologia. (Oct. 2024). DOI:https://doi.org/10.4081/aiua.2024.12833.